ketoconazole prostate cancer

Prostate Cancer Treatment (PDQ®) - National Cancer Institute

Sep 21, 2012 . Chemotherapy for Hormone-Refractory Prostate Cancer . [36] Survival rates are similar whether ketoconazole plus hydrocortisone is initiated .
http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page9

High Dose Ketoconazole (Nizoral) Plus Hydrocortisone - HRPCa

The focus here is on HDK. High Dose Ketoconazole(HDK). In cases where prostate cancer (PCa) is not considered treatable with a prostatectomy or radiation, .
http://www.hrpca.org/HDK.html

Sponsor:
Information provided by (Responsible Party):

Contemporary experience with ketoconazole in patients with ...

Jun 17, 2011 . Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: clinical factors associated with PSA .
http://www.ncbi.nlm.nih.gov/pubmed/21688281

Ketoconazole in Taiwanese castration-resistant prostate cancer ...

To evaluate the efficacy of ketoconazole in castration-resistant prostate cancer. We reviewed the medical records of consecutive patients with pathologically con.
http://www.sciencedirect.com/science/article/pii/S1879522612000310

NCT00895310

Ketoconazole - Wikipedia, the free encyclopedia

Due to its efficacy at reducing systemic androgen levels, ketoconazole has been used as a treatment for androgen-dependent prostate cancer. Second .
http://en.wikipedia.org/wiki/Ketoconazole

A new way to treat prostate cancer: The story of abiraterone

Sep 10, 2012 . The team started with a drug called ketoconazole, which they noticed prevented the growth of prostate cancer cells. The drug worked by .
http://www.icr.ac.uk/press/recent_featured_articles/Story_Abiraterone/index.shtml

Last verified: June 2012
  Purpose

Efficacy of ketoconazole in castration-refractory prostate cancer: A ...

T. J. Fillos, D. Chu, S. Wu. Abstract Disclosures. Abstract: Introduction: Ketoconazole in combination with hydrocortisone has been used in the treatment of .
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=54&abstractID=20076

Use of Low Dose Ketoconazole in Prostate Cancer - ClinicalTrials.gov

Jun 29, 2012 . The purpose of this study is to test the safety of ketoconazole and how well it works after chemotherapy has been used. Ketoconazole at lower .
http://clinicaltrials.gov/ct2/show/NCT00895310


kenmore 110 manual combo kelly clarkson miss independent lyric kenia viva cuba 8th street latinas
Prostate Cancer
Drug: Ketoconazole
Phase 2

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Assessing PSA Response in Low Dose Ketoconazole in Hormone Refractory Prostate Cancer Patients Who Have Failed at Least One Prior Systemic Chemotherapy Regimen

Resource links provided by NLM:


Ketoconazole: From an antimycotic to a drug for prostate cancer

Key words: sex steroids, ketoconazole, prostate cancer. INTRODUCTION. Ketoconazole is an oral antifungal imidazole derivative that is active against a broad .
http://onlinelibrary.wiley.com/doi/10.1002/ddr.430080134/pdf


Primary Outcome Measures:
  • Chemoregimen - Prostate Cancer

    Antiandrogen withdrawl alone or in combination with ketoconazole in androgen- independent prostate cancer patients: a phase III trial (CALGB 9583).
    http://chemoregimen.com/Prostate-Cancer-c-51-61.html



Secondary Outcome Measures:
  • Lupron and Casodex and Now Provenge? Ketoconazole? Zytiga ...

    My husband has been battling prostate cancer since January of 2004. Had radical prostatectomy in April 2004. April 2005, had recurrence .
    http://www.inspire.com/groups/us-too-prostate-cancer/discussion/lupron-and-casodex-and-now-provenge-ketoconazole-zytiga/



Estimated Enrollment: 30
Study Start Date: May 2009
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
kenmore 90 series dryer manual keystone mag wheels
Experimental: Ketoconazole Drug: Ketoconazole

High Dose Ketoconazole Plus Hydrocortisone - Prostate Cancer ...

High-dose ketoconazole (HDK) is an oral broad-spectrum anti-prostate cancer ( PC) agent that has testosterone lowering effects through its abilities to decrease .
http://prostate-cancer.org/high-dose-ketoconazole-plus-hydrocortisone-hdk-hc/

Other Name: Nizoral

kevin windham myspace layouts Detailed Description:

High-dose ketoconazole in advanced hormone-refractory prostate ...

While ketoconazole with hydrocortisone does suppress plasma androgens in advanced prostatic cancer patients, this infrequently causes regression of cancer .
http://jco.ascopubs.org/content/7/8/1093

PROSTATE CANCER COMMUNICATION HIGH DOSE ...

Sep 3, 2010 . high dose (800-1200 mg) ketoconazole (HDK) was effective against prostate cancer even after the development of hormone resistance.
http://paactusa.org/uploads/Sept2010_9329.pdf

Funding from PCCTC Advances Study of Ketoconazole and Docetaxel

June 3, 2012—Ketoconazole (keto) is drug used in prostate cancer to block the release of testosterone from the adrenal glands, typically administered in .
http://www.pcf.org/site/c.leJRIROrEpH/b.8102739/k.D98D/Funding_from_PCCTC_Advances_Study_of_Ketoconazole_and_Docetaxel_Response_Following_Abiraterone_Acetate.htm

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ketoconazole: MedlinePlus Drug Information

    A small number of patients who were taking high doses of ketoconazole for prostate cancer died soon after they began taking the medication. It is not known .
    http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682816.html

  • How is ketoconazole used to treat prostate cancer? - Sharecare

    How is the antifungal ketoconazole used to treat prostate cancer? In very high doses, the antifungal ketoconazole rapidly lowers blood levels of testosterone .
    http://www.sharecare.com/question/how-ketoconazole-treat-prostate-cancer

  • Patients must be >18 years old
  • Patients must have received at least one prior chemotherapy regimen >3 weeks prior to initiation of study and patients must have recovered from the side effects of the therapy
  • Patients must have an ECOG status of 0-3
  • Secondary endocrine therapies for castration resistant prostate cancer

    Aug 9, 2012 . Antiandrogen withdrawal alone or in combination with ketoconazole in androgen -independent prostate cancer patients: a phase III trial .
    http://www.uptodate.com/contents/secondary-endocrine-therapies-for-castration-resistant-prostate-cancer

  • The treatment of advanced prostate cancer with ketoconazole: safety ...

    The treatment of advanced prostate cancer with ketoconazole: safety issues. Bok RA, Small EJ. University of California, San Francisco, 94143, USA.
    http://www.ncbi.nlm.nih.gov/pubmed/10348095

  • Patients must have a serum total testosterone level <50 ng/dl
  • Ketoconazole retains activity in patients with docetaxel-refractory ...

    The activity of ketoconazole in this clinical state has not previously been . ketoconazole in patients with castration-resistant metastatic prostate cancer who had .
    http://annonc.oxfordjournals.org/content/20/5/965.2.full

    KETOCONAZOLE (HIGH DOSE/HDK ... - The Prostate Advocate

    KETOCONAZOLE (HIGH DOSE/HDK) GUIDELINES. (Compiled by Charles ( Chuck) Maack – Prostate Cancer Advocate). Disclaimer: Please recognize that I am .
    http://www.theprostateadvocate.com/pdf/KETOCONAZOLE.pdf

Exclusion Criteria:

  • Patients with any condition that impairs the ability to swallow medications orally
  • Patients who are unable to give informed consent
  • Patients who have received ketoconazole treatment for prostate cancer in the past
  • Patients with other active malignancies in the past 3 years except nonmelanoma skin cancer
  • Patients may not be receiving any other investigational agents
  • Patients with known hypersensitivity to ketoconazole
  • Abiraterone Acetate and Ketoconazole in Prostate Cancer Patients ...

    Aug 22, 2011 . Chicago—A study of patients with progressive metastatic castration-resistant prostate cancer (mCRPC) who had previously used ketoconazole .
    http://www.firstreportnow.com/articles/abiraterone-acetate-and-ketoconazole-prostate-cancer-patients

  Contacts and Locations

MARY and JOHN'S story « Prostablog

The partner of a Kiwi man battling prostate cancer tells her story MARY is the partner . The bad news is that it looks like Ketoconazole is off the prostate cancer .
http://prostablog.wordpress.com/older-stuff/prostate-stories/mary-johns-prostate-saga/



Contacts

Efficacy of Low-dose Ketoconazole in Hormone Refractory Prostate ...

36 No. 10. 811. Efficacy of Low-dose Ketoconazole in HRPC—Lynette SM Ngo et al. Efficacy of Low-dose Ketoconazole in Hormone Refractory Prostate Cancer .
http://www.annals.edu.sg/pdf/36VolNo10Oct2007/V36N10p811.pdf

916-734-3771 kenya simmons stripper

EFFICACY OF KETOCONAZOLE IN HORMONE REFRACTORY ...

This study aims to describe our experience with ketoconazole treatment for hormone refractory prostate cancer (HRPC) at our centre. Retrospective chart review .
http://www.banglajol.info/index.php/JOM/article/download/2814/2330

916-734-7946 kentucy fried chicken coupon

kendra holly nude playboy
Locations

An Evaluation of Intermediate-Dose Ketoconazole in Hormone ...

An Evaluation of Intermediate-Dose Ketoconazole in Hormone Refractory Prostate Cancer. Simon Wilkinson, Gerald Chodak. Accepted 26 November 2003 , .
http://www.europeanurology.com/article/S0302-2838(03)00677-8/abstract

Prostate Oncology Specialists - Glossary

Subsequently it was discovered that high dose Ketoconazole (HDK) is effective against prostate cancer even after the development of hormone resistance.
http://www.prostateoncology.com/education/glossary/a:2d_hormonal_therapy

Recruiting

About Dosing Ketoconazole - Malecare's Advanced Prostate Cancer

Feb 3, 2011 . There are two different dosage levels used for the administration of Ketoconazole (Keto), a commonly used 2nd line hormone deprivation drug .
http://advancedprostatecancer.net/?p=2318

Ketoconazole retains activity in advanced prostate cancer patients with

MATERIALS AND METHODS: A total of 50 consecutive patients with advanced prostate cancer received ketoconazole and hydrocortisone at progression after .
http://www.ncbi.nlm.nih.gov/pubmed/9120902

Sponsors and Collaborators

Long-term outcome for men with androgen independent prostate ...

PURPOSE: The combination of high dose ketoconazole and hydrocortisone ( HDK) is active against androgen independent prostate cancer (AIPC). Median .
http://www.ncbi.nlm.nih.gov/pubmed/15879788

Investigators
Principal Investigator:

High-dose ketoconazole in castration-resistant, metastatic prostate ...

High-dose ketoconazole in castration-resistant, metastatic prostate cancer patients previously treated with docetaxel chemotherapy: Single institution .
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=74&abstractID=54662

Efficacy of low-dose ketoconazole in hormone refractory prostate ...

Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore. Ngo LS .
http://www.ncbi.nlm.nih.gov/pubmed/17987231

  More Information

No publications provided

Responsible Party:

Activity of dutasteride plus ketoconazole in castration-refractory ...

BACKGROUND: Ketoconazole is a commonly used secondary hormonal therapy in castration-refractory prostate cancer (CRPC), but disease progression .
http://www.ncbi.nlm.nih.gov/pubmed/19815488

Indications for use of ketoconazole in management of metastatic ...

Indications for use of ketoconazole in management of metastatic prostate cancer. Lowe FC, Bamberger MH. Department of Urology, St. Luke's/Roosevelt .
http://www.ncbi.nlm.nih.gov/pubmed/2247927

keystone raider wheels pics     kiesha cole cd
Other Study ID Numbers:

Rationale for combination ketoconazole/ vitamin D treatment of ...

Rationale for combination ketoconazole/ vitamin D treatment of prostate cancer. Peehl DM, Seto E, Feldman D. Department of Urology, Stanford University .
http://www.ncbi.nlm.nih.gov/pubmed/11502466

Study First Received: May 6, 2009
Last Updated: June 29, 2012
Health Authority: United States: Institutional Review Board

Low dose ketoconazole with replacement doses of hydrocortisone in ...

oral ketoconazole 3 times daily with replacement doses of hydrocortisone has become a standard treatment option for patients with advanced prostate cancer .
http://www.ncbi.nlm.nih.gov/pubmed/12131305

PSA
Ketoconazole
Prostate Cancer
Hormone Refractory
Chemotherapy Regimen

Additional relevant MeSH terms:
Prostatic Neoplasms

Ketoconazole and Dexamethasone in Prostate Cancer - Full Text ...

Mar 19, 2012 . This is an open label, phase II, single center trial of ketoconazole/ dexamethasone to determine if the administration of .
http://clinicaltrials.gov/ct2/show/NCT01036594


Urogenital Neoplasms
Neoplasms by Site
Neoplasms

Activity of dustasteride plus ketoconazole in hormone-refractory ...

Introduction: Ketoconazole is commonly used as a secondary hormonal therapy in patients with hormone-refractory prostate cancer (HRPC), but disease .
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=46&abstractID=20212


Prostatic Diseases
Hormones
Ketoconazole

Activity of ketoconazole after taxane-based chemotherapy in ...

Oct 23, 2009 . Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer. Nakabayashi M, Oh WK, Jacobus S, Regan .
http://www.ncbi.nlm.nih.gov/pubmed/19863532


Physiological Effects of Drugs
Pharmacologic Actions
14-alpha Demethylase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Antifungal Agents
Anti-Infective Agents
Therapeutic ketoconazole prostate cancers

Metastatic and Advanced Prostate Cancer

Sep 27, 2012 . Prostate cancer is the second leading cause of cancer-related deaths in . Most prostate cancer–related deaths are due to advanced disease, .
http://emedicine.medscape.com/article/454114-overview